Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

We found the following factors were important for predicting the progression of glaucoma: (1) the presence of small bleeding and poor blood flow to the retina and back of the eye, (2) abnormal cell ...

Researchers have found in a new study that personal wealth is strongly associated with outcomes 12–18 months after a new ...

ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S.

Press Release Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026All clinical trial and ...

In a survey, nearly two-thirds of patients with glaucoma or ocular hypertension were unaware of preservative-free topical ...

The MarketWatch News Department was not involved in the creation of this content.-- The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sac ...

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the ...

A new analysis linking clinical and census data finds individual factors, rather than neighborhood conditions, are more strongly associated ...

At Specsavers Victoria Square in Bolton, there are between 30 and 50 GERS appointments each month. Thornton highlighted that ...

Learn more about whether Ocular Therapeutix, Inc. or Wave Life Sciences Ltd. is a better investment based on AAII's A+ ...